Rationale for the clinical use of adipose-derived mesenchymal stem cells for COVID-19 patients - Rogers, Christopher J.; Harman, Robert J.; Bunnell, Bruce A.; Schreiber, Martin A.; Xiang, Charlie; Wang, Fu-Sheng; Santidrian, Antonio F.; Minev, Boris R. (Journal of translational medicine, 2020)
Keywords: Adipocytes; Alveoli; Animal models; Animals; ARDS; Betacoronavirus - physiology; Bone marrow; Clinical trials; Clinical Trials as Topic; Coronavirus Infections - therapy; Coronaviruses; COVID-19; Cytokines; Edema; Epidemics; Fever; Health aspects; Humans; Hypoxia; Immune clearance; Immune response; Immunomodulation; Immunomodulators; Infections; Inflammation; Intravenous administration; Lung diseases; Medical research; Mesenchymal Stem Cell Transplantation - adverse effects; Mesenchymal stem cells; Mesenchymal Stem Cells - cytology; Morbidity; Mortality; Neutrophils; Outbreaks; Pandemics; Pathogenesis; Patients; Pneumonia; Pneumonia, Viral - therapy; Pulmonary fibrosis; Respiratory diseases; Respiratory distress syndrome; Respiratory function; Review; SARS-CoV-2; Severe acute respiratory syndrome coronavirus 2; Stem cell transplantation; Stem cells; United Kingdom; United Kingdom; COVID-19; Pneumonia; SARS-CoV-2; ARDS; Mesenchymal stem cells